Announcements
Clinical and Experimental Obstetrics & Gynecology (CEOG) is published by IMR Press from Volume 47 Issue 1 (2020). Previous articles were published by another publisher on a subscription basis, and they are hosted by IMR Press on imrpress.com as a courtesy and upon agreement with S.O.G.
Review
Is there a place for menopausal hormonal therapy in the treatment of postmenopausal osteoporosis?
Show Less
1
Department of Gynecological Endocrinology, Poznań University of Medical Sciences, Poznań, Poland
2
Poznań University of Medical Sciences, Poznań, Poland
3
Department of Operative Gynecology, Poznań University of Medical Sciences, Poznań, Poland
4
Stanisław Wojciechowski Vocational State School, Kalisz, Poland
Clin. Exp. Obstet. Gynecol. 2018, 45(3), 325–327;
https://doi.org/10.12891/ceog3947.2018
Published: 10 June 2018
Abstract
Postmenopausal osteoporosis is a major problem for public health. In the past, osteoporosis was one of the primary indications for menopausal hormonal therapy (MHT), but actually it has been downgraded to second-line therapy In this review the authors would like to discuss actual data on the role of estrogen and progestins in the bone metabolism and the results of clinical studies related to MHT.
Keywords
Osteoporosis
Menopause
Aging
Menopausal hormonal therapy
Fracture